Please assess the completion status of the following clinical trial:

Trial Title: Study to Intervene With Nutrition for Gastroparesis

Study Design Characteristics:
- Allocation: None
- Intervention Model: SINGLE_GROUP
- Observational Model: None
- Primary Purpose: SUPPORTIVE_CARE
- Time Perspective: None
- Masking: NONE
- Phase: None
- Number of Arms: 1.0

Eligibility Criteria:
Identify inclusion criteria.~* Male or female gender~* Ages 18 to 65~* Established diagnosis of gastroparesis confirmed by gastric emptying study within the last 5 years.~* No changes to gastroparesis medications in the 3 months prior to recruitment.~* Patients with hysterectomy, appendectomy, cholecystectomy and fundoplication are ok to participate.~* Able to give informed consent.~* Patient willing to supplement diet with Kate Farms~* Ability to adhere to the study visit schedule and other protocol requirements.~Identify exclusion criteria.~* Are nursing or pregnant.~* Diagnosis of mechanical small bowel obstruction within 3 months prior to recruitment~* Patients with a history of gastric surgery, including gastrectomy, small bowel resection or bariatric surgery~* The use of narcotic medications in the month prior to study enrollment or during the study period~* Diagnosis of short gut syndrome~* Allergic to any ingredients in the Kate Farms formula~* Untreated small intestinal bacterial overgrowth

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: 65 Years
- Healthy Volunteers: f

Study Arms:
- Assess Nutritional Effects of Nutritional Formula (Type: OTHER): Self-controlled study in which we will assess the nutritional effects of the Kate Farm Peptide 1.5 nutritional Formula in patients with gastroparesis, relative to their pre-enrollment nutritional formula regimen.

Based on this trial design, predict the completion outcome and termination type (if applicable).